Visier Wins Gold at 2024 HRM Asia Reader's Choice Awards
Company Recognized for "Best HR Tech - HR Data and Analytics Solutions" SINGAPORE, Dec. 17, 2024 /PRNewswire/ -- Visier, the globally recognized leader in workforce AI solutions, is proud to announce the company has been awarded the Gold Award for...
Yeahka's Overseas Business Becomes a New Growth Engine, with 50% YoY Payment GPV Growth in Q3
HONG KONG, Dec. 17, 2024 /PRNewswire/ -- While the world is reshaping global economic landscape, Chinese companies had begun to embark on a new wave of international expansion. As a fundamental component of economic activities, payment services play...
Ultima Markets makes history as the first CFD broker to join the United Nations Global Compact initiative
NEW YORK, Dec. 17, 2024 /PRNewswire/ -- Ultima Markets, a leading CFD trading services provider, is proud to announce that it has joined the United Nations Global Compact initiative, becoming the first CFD broker to participate in this drive. UN...
Traveloka Reveals 3 Last-Minute Travel Hacks for Year End Getaways
Win a Travel Voucher worth up to SGD 2,000 and Enjoy Limited Flash Sales at Traveloka Year-End Sale! SINGAPORE, Dec. 17, 2024 /PRNewswire/ -- Planning your year-end travel just got easier! Traveloka, Southeast Asia's leading travel platform, invites...
Amai Proteins succesfully completed world's first human clinical trial on effects of sweet proteins, with sweelin®
REHOVOT, Israel, Dec. 17, 2024 /PRNewswire/ -- Amai Proteins, a scale-up designer of novel proteins that answer the needs of consumers and industry, has succesfullly completed world's first double-blind, random clinical trial on the effects of their...
Rizhao's low-altitude economy takes off
RIZHAO, China, Dec. 16, 2024 /PRNewswire/ -- A news report from chinadaily.com.cn - The first Low-altitude Economy Carnival was recently held in Rizhao, Shandong, marking a significant milestone in the city's burgeoning low-altitude economy. The...
SK Biopharmaceuticals Inks Research Collaboration Agreement with ProEn Therapeutics Further Accelerating Expansion of Oncology Research and Pipeline for Global Competitiveness in Radiopharmaceuticals
SK Biopharmaceuticals, ProEn Therapeutics aim to advance up to 2 preclinical radiopharmaceutical candidates by 2027, via ArtBody™, a bivalent binder platform designed to selectively target tumor cells SK Biopharmaceuticals eyes innovative small...
Omi wraps up 2024 dating trends
SINGAPORE, Dec. 17, 2024 /PRNewswire/ -- Drawing insights from over 25,000 users aged 18 to 35 across key markets, Omi observes a shift in 2024 dating trends towards autonomous and intentional connections. This includes women taking the lead in...